酒精性肝硬化相关IgA肾病的临床表现、病理谱与结局
这项回顾性多中心研究分析了2009至2022年确诊的46例肝硬化相关IgA肾病(肝硬化-IgAN)患者,并与83例原发性IgA肾病(pIgAN)进行聚类分析。结果显示肝硬化-IgAN临床表现严重,79%出现急性肾损伤(AKI),62%的AKI存在其他原因;识别出三个临床病理聚类,其中膜增生性肾小球肾炎(MPGN)模式在肝硬化患者中更常见。肝硬化-IgAN的1年累积死亡率为26%,3年为46%,激素暴露与中度或重度AKI与更高死亡率相关,激素暴露还与严重感染发生相关。
要点
- 肝硬化-IgAN患者AKI发生率高(79%),多数(62%)存在其他原因。
- MPGN模式在肝硬化-IgAN中更常见,与大量蛋白尿和内在AKI相关。
- 激素暴露与严重感染及死亡率升高相关,需谨慎使用免疫抑制治疗。
核心结论
- 肝硬化-IgAN中高AKI发生率多数由外源性因素导致,但部分患者可由IgA优势的MPGN驱动。
- 激素使用与感染性疾病和死亡率相关,免疫抑制治疗的作用需进一步研究。
研究设计与样本
- 回顾性多中心研究,纳入2009至2022年经肾活检确诊的46例肝硬化相关IgA肾病患者,并与同期83例原发性IgA肾病患者进行聚类分析。
主要发现
- 所有46例肝硬化-IgAN患者均有过度酒精消耗。
- 临床表现严重,79%出现急性肾损伤(AKI),其中62%的病例发现其他AKI原因。
- 识别出三个临床病理聚类:第一类代表慢性受累,第二类类似轻度疾病,第三类对应膜增生性肾小球肾炎(MPGN)模式,与大量蛋白尿和内在AKI(无其他原因)相关。
- 前两个聚类在pIgAN和肝硬化-IgAN中分布均等,第三类在肝硬化患者中更常见。
- 肝硬化-IgAN的累积死亡率1年为26%,3年为46%;激素暴露和中度或重度AKI与更高死亡率相关,激素暴露与严重感染发生相关。
临床怎么用
- 对于肝硬化-IgAN患者,应积极寻找AKI的其他原因,而非默认由IgA肾病活动引起。
- 使用激素治疗肝硬化-IgAN需权衡感染和死亡风险,尤其在中度或重度AKI患者中。
局限性
- 回顾性研究设计可能引入选择偏倚和信息偏倚。
- 样本量较小(46例肝硬化-IgAN),结论需更大规模研究验证。
- 未明确免疫抑制治疗在肝硬化-IgAN中的角色,需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Immunoglobulin A nephropathy (IgAN) associated with cirrhosis is frequent but often overlooked because it is largely considered silent. Until now, little has been known about their presentation and outcomes. METHODS: We conducted a retrospective multicenter study on patients with kidney biopsy-proven cirrhosis-related IgAN (cirrhosis-IgAN), diagnosed between 2009 and 2022. We mixed them up with 83 primary IgAN (pIgAN) diagnosed during the same period, using a partitioning clustering approach, to determine common clinicopathological profiles. RESULTS: All the 46 patients with cirrhosis-IgAN had an excessive alcoholic consumption. Clinical presentation was severe with acute kidney injury (AKI) in 79%; alternative causes of AKI was found in 62% of cases. Three clinicopathological clusters were identified as follows: the first one represented chronic involvement, the second one could be assimilated to mild disease, and the third one corresponded to a membranoproliferative glomerulonephritis (MPGN) pattern and was associated with heavy proteinuria and intrinsic AKI (without alternative causes). Whereas the first 2 clusters were equally distributed between pIgAN and cirrhosis-IgAN, the third was more frequent in patients with cirrhosis. The cumulative mortality rate in cirrhosis-IgAN was 26% and 46% at 1-year and 3-years, respectively. Steroid exposure and moderate or severe AKI were associated with higher mortality and steroid exposure was associated with the occurrence of severe infection. CONCLUSION: Our results suggest that high AKI incidence is related to extrinsic causes in most cases but can also be driven by IgA-dominant MPGN in a subset of patients. Steroid use was associated with infectious disease and mortality. Further studies are needed to clarify the role of immunosuppressive treatment in cirrhosis-IgAN patients.
引用
- Ronsin C, Braud P, Kandel-Aznar C, et al. Clinical Presentation, Pathological Spectrum, and Outcomes of Alcoholic Cirrhosis-Related Immunoglobulin A Nephropathy. Kidney Int Rep. 2024. PMID: 38707818. doi:10.1016/j.ekir.2024.02.1397
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。